Approval · Notice of Compliance 6019 · 2004
VAQTA: Notice of Compliance 6019
Issued December 23, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6019
- Date
- December 23, 2004
- Company
- Merck Frosst Canada & Cie, Merck Frosst Canada & Co.Kirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing facility
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VAQTA | Not yet assigned | — |
Medicinal ingredients
- HEPATITIS A VACCINE, INACTIVATED 50 UNIT per 1ML